Reply to ‘Empagliflozin and glucagon‐like peptide‐1 receptor agonists: The brothers for heart failure?’
Author:
Affiliation:
1. UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology Faculty of Medicine, University of Porto Porto Portugal
2. University of Groningen Groningen The Netherlands
Publisher
Wiley
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.3415
Reference4 articles.
1. Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post‐hoc analysis from EMPULSE
2. Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
3. Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials
4. Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3